Cytomos Company Profile
Cytomos, founded in 2011 and based in Edinburgh, Scotland, is a private biotechnology company specializing in patented dielectric spectroscopy technology for label-free, granular cell analysis to enhance biomedical research applications such as drug discovery and stem cell therapy, having raised $15.4 million in funding including a recent $7.79 million later-stage VC round, supported by investors like British Business Bank and Innovate UK, and holding 33 patent documents with 12 granted and 14 pending.
Overview
Cytomos is a developer of dielectric spectroscopy technology designed for label-free cell analysis in biomedical research. Their patented technology analyzes every cell, providing granular information on individual cells and the entire sample population. This facilitates automated and quantitative sample assessment, phenotypic drug discovery, and stem cell therapy, enabling medical researchers to find functional endpoints and generate content fingerprints to prepare the right dose, making cell-based diagnostics more efficient.
- Year Founded: 2011
- Status: Private
- Employees: 30
- Primary Industry: Biotechnology
- Other Industries: Laboratory Services (Healthcare)
- Location: 1st Floor, Charles Darwin House, Milton Bridge, The Edinburgh Technopole, Edinburgh EH26 0PY, Scotland, United Kingdom
- Website: www.cytomos.com
Valuation & Funding
- Latest Deal Type: Later Stage VC
- Latest Deal Amount: $7.79M (29-Oct-2024)
- Total Funding Raised: $15.4M
- Previous Rounds:
- Grant (01-Dec-2022)
- Seed Rounds (2014–2022)
- Notable earlier rounds: $768K (01-Mar-2016), $157K (15-Dec-2014)
Cap Table (Selected)
- Ordinary Shares: 35,295 at $0.000013 par value, $8.91 issue price, 2.39% owned
- Ordinary Shares: 126,050 at $0.000013 par value, $6.63 issue price, 8.55% owned
Investors
- British Business Bank (Lender/Debt Provider, Minority)
- Innovate UK (Government)
- Old College Capital (Venture Capital, Minority)
- Scottish Enterprise (Growth/Expansion, Minority)
- Archangel Investors (Angel Group, Minority)
Patents
- Total Documents (Applications and Grants): 33
- Total Patent Families: Not specified
- Granted: 12
- Pending: 14
- Recent Patent Activity:
- GB-202509620-D0: Cell analysis (Pending, 18-Jun-2025)
- GB-202414700-D0: Cell analysis (Inactive, 07-Oct-2024)
- GB-202413794-D0: Cell analysis (Pending, 19-Sep-2024)
- GB-2644194-A: Cell analysis (Pending, 19-Sep-2024)
- WO-2026062381-A1: Cell analysis (Pending, 19-Sep-2024, G01N15/0656)
FAQs
When was Cytomos founded?
Cytomos was founded in 2011.
Where is Cytomos headquartered?
Cytomos is headquartered in Edinburgh, United Kingdom.
What is the size of Cytomos?
Cytomos has 30 total employees.
What industry is Cytomos in?
Cytomos’s primary industry is Biotechnology.
Is Cytomos a private or public company?
Cytomos is a private company.
How much funding has Cytomos raised over time?
Cytomos has raised $15.4M.
Who are Cytomos’s investors?
British Business Bank, Innovate UK, Old College Capital, Scottish Enterprise, and Archangel Investors have invested in Cytomos.